The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
Open accessAbstract
Somatic gene therapy has been proposed as a means to achieve systemic delivery of therapeutic proteins. However, there is limited evidence that current methods of gene delivery can practically achieve this goal. In this study, we demonstrate that, following a single intramuscular administration of a recombinant adeno-associated virus (rAAV) vector containing the β-galactosidase (AAV-lacZ) gene into adult BALB/c mice, protein expression was detected in myofibers for at least 32 weeks. A single intramuscular administration of an AAV vector containing a gene for human erythropoietin (AAV-Epo) into mice resulted in dose-dependent secretion of erythropoietin and corresponding increases in red blood cell production that persisted for up to 40 weeks. Primary human myotubes transduced in vitro with the AAV-Epo vector also showed dose-dependent production of Epo. These results demonstrate that rAAV vectors are able to transduce skeletal muscle and are capable of achieving sustained expression and systemic delivery of a therapeutic protein following a single intramuscular administration. Gene therapy using AAV vectors may provide a practical strategy for the treatment of inherited and acquired protein deficiencies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.
Wigler, M., Pellicer, A., Silverstein, S., Axel, R., Urlaub, G., & Chasin, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1373 · Cited by 1,279
Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos.
Sanes, J. R., Rubenstein, J. L., & Nicolas, J. F. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04620.x · Cited by 1,105
Kaplitt, M. G., Leone, P., Samulski, R. J., Xiao, X., Pfaff, D. W., O'Malley, K. L., & During, M. J. (1994) · Nature Genetics · doi:10.1038/ng1094-148 · Cited by 1,031
Integration of murine leukemia virus DNA depends on mitosis.
Roe, T., Reynolds, T. C., Yu, G., & Brown, P. O. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05858.x · Cited by 921
Ferrari, F. K., Samulski, T., Shenk, T., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3227-3234.1996 · Cited by 761
Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
Muzyczka, N. (1992) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75608-5_5 · Cited by 754
Tripathy, S. K., Black, H. B., Goldwasser, E., & Leiden, J. M. (1996) · Nature Medicine · doi:10.1038/nm0596-545 · Cited by 628
Yang, Y., Ertl, H. C. J., & Wilson, J. M. (1994) · Immunity · doi:10.1016/1074-7613(94)90074-4 · Cited by 611
Widespread long-term gene transfer to mouse skeletal muscles and heart.
Stratford-Perricaudet, L. D., Makeh, I., Perricaudet, M., & Briand, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115902 · Cited by 580
Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R., Burda, J. F., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.520-532.1996 · Cited by 547
Flotte, T. R., Afione, S. A., Conrad, C., McGrath, S. A., Solow, R., Oka, H., Zeitlin, P. L., Guggino, W. B., & Carter, B. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10613 · Cited by 490
Yang, Y., Nunes, F. A., Berencsi, K., Gönczöl, E., Engelhardt, J. F., & Wilson, J. M. (1994) · Nature Genetics · doi:10.1038/ng0794-362 · Cited by 450
Gussoni, E., Pavlath, G. K., Lanctot, A. M., Sharma, K. R., Miller, R. G., Steinman, L., & Blau, H. M. (1992) · Nature · doi:10.1038/356435a0 · Cited by 434
Isolation and characterization of human muscle cells.
Blau, H. M., & Webster, C. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5623 · Cited by 399
Yang, Y., Jooss, K. U., Su, Q., Ertl, H. C. J., & Wilson, J. M. (1996) · PubMed · Cited by 375
Davis, H. L., Whalen, R. G., & Demeneix, B. A. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.2-151 · Cited by 371
Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient Rabbits
Chowdhury, J. R., Grossman, M., Gupta, S., Chowdhury, N. R., Baker, J. R., & Wilson, J. M. (1991) · Science · doi:10.1126/science.1722351 · Cited by 366
Yang, Y., Janich, S., Cohn, J. A., & Wilson, J. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9480 · Cited by 337
Systemic Delivery of Human Growth Hormone by Injection of Genetically Engineered Myoblasts
Dhawan, J., Pan, L. C., Pavlath, G. K., Travis, M. A., Lanctot, A. M., & Blau, H. M. (1991) · Science · doi:10.1126/science.1962213 · Cited by 317
Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle
Davis, H. L., Demeneix, B. A., Quantin, B., Coulombe, J., & Whalen, R. G. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-733 · Cited by 307
Systemic Delivery of Recombinant Proteins by Genetically Modified Myoblasts
Barr, E., & Leiden, J. M. (1991) · Science · doi:10.1126/science.1962212 · Cited by 281
Adeno-associated virus vectors preferentially transduce cells in S phase.
Russell, D. W., Miller, A. D., & Alexander, I. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8915 · Cited by 275
Plasmid DNA entry into postmitotic nuclei of primary rat myotubes.
Dowty, M. E., Williams, P., Zhang, G., Hagstrom, J. E., & Wolff, J. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4572 · Cited by 270
The cryptic life style of adenoassociated virus
Berns, K. I., & Linden, R. M. (1995) · BioEssays · doi:10.1002/bies.950170310 · Cited by 268
Gene transfer into the mouse retina mediated by an adeno-associated viral vector
Ali, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.591 · Cited by 255
Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors
Podsakoff, G., Wong, K. K., & Chatterjee, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5656-5666.1994 · Cited by 231
Self-citationFlotte, T. R., Afione, S. A., & Zeitlin, P. L. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.11.5.7946381 · Cited by 225
Alexander, I. E., Russell, D. W., & Miller, A. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8282-8287.1994 · Cited by 222
Acsadi, G., Jani, A., Massie, B., Simoneau, M., Holland, P., Blaschuk, K., & Karpati, G. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.4.579 · Cited by 207
The use of DNA viruses as vectors for gene therapy.
Ali, M., Lemoine, N. R., & Ring, C. (1994) · PubMed · Cited by 200
Gene Expression from Adeno-associated Virus Vectors in Airway Epithelial Cells
Flotte, T. R., Solow, R., Owens, R. A., Afione, S., Zeitlin, P. L., & Carter, B. J. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/7.3.349 · Cited by 167
Expression of human factor IX in mice after injection of genetically modified myoblasts.
Yao, S.-N., & Kurachi, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3357 · Cited by 139
Tripathy, S. K., Goldwasser, E., Lu, M. M., Barr, E., & Leiden, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11557 · Cited by 117
Blau, H. M., & Springer, M. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332308 · Cited by 106
Gene Therapy — Promise, Pitfalls, and Prognosis
Leiden, J. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331310 · Cited by 103
Long-Term Secretion of Therapeutic Proteins from Genetically Modified Skeletal Muscles
Naffakh, N., Pinset, C., Montarras, D., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.1-11 · Cited by 72
Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells
Hunter, L. A., & Samulski, R. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.317-324.1992 · Cited by 68
Gene therapy for long-term expression of erythropoietin in rats.
Osborne, W. R. A., Ramesh, N., Lau, S., Clowes, M. M., Dale, D. C., & Clowes, A. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.8055 · Cited by 60
Galson, D., Tan, C., Ratcliffe, P. J., & Bunn, H. F. (1993) · Blood · doi:10.1182/blood.v82.11.3321.3321 · Cited by 29
Cited by
Adeno-associated virus vector as a platform for gene therapy delivery
Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444
Dunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018) · Science · doi:10.1126/science.aan4672 · Cited by 1,410
“in vivo muscle administration of AAV vectors to mice (35, 36).”
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Self-citationImmune responses to AAV vectors: overcoming barriers to successful gene therapy
Mingozzi, F., & High, K. A. (2013) · Blood · doi:10.1182/blood-2013-01-306647 · Cited by 955
“23,24 The fi rst trials of AAV vectors in human subjects were in the setting of cystic fi brosis 25 ; the fi rst trial in hemophilia B, in which vector was injected into skeletal muscle, began in 1999.”
Metadata
- Authors
- Kessler, P. D., Podsakoff, G. M., Chen, X., McQuiston, S. A., Colosi, P. C., Matelis, L. A., Kurtzman, G. J., & Byrne, B. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-11-26
- Volume
- 93
- Issue
- 24
- Pages
- 14082-14087
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2014010760
- Cited by
- 614
- References
- 41
- FWCI
- 25.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.